Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...
The One Medicine Platform replaces 20+ legacy platforms—unifying medicinal development processes & data sources into a ...
Boehringer Ingelheim has prevailed in the trial of two lawsuits claiming that its discontinued heartburn drug Zantac caused cancer, both of which had previously ended with hung juries. November 22 ...
Boehringer Ingelheim and Veeva Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They ...